Castration-Sensitive Prostate Carcinoma
8 clinical trials · Condition
◉ Watch Castration-Sensitive Prostate Carcinoma
| Record | Firm | Date |
|---|---|---|
| Talazoparib With Androgen Deprivation Therapy and Abiraterone for the Treatment of Castration Sensitive Prostate Cancer (NCT04734730) | City of Hope Medical Center | 2021-05-04 |
| Antiandrogen Therapy, Abiraterone Acetate, and Prednisone With or Without Neutron Radiation Therapy in Treating Patients With Prostate Cancer (NCT03649841) | University of Washington | 2020-06-29 |
| Advanced ChemoHormonal Therapy for Treatment Naive Metastatic Prostate Cancer (NCT04267887) | OHSU Knight Cancer Institute | 2020-05-11 |
| Docetaxel or Abiraterone Acetate With ADT in Treating Patients With Metastatic Hormone Sensitive Prostate Cancer (NCT03827473) | University of Utah | 2019-02-08 |
Track Castration-Sensitive Prostate Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.